Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche Sequencing Solution of Roche is focused on developing novel technologies and products to support innovation in clinical research applications. Part of Roche Sequencing Solutions, the Harmony® prenatal test is a non-invasive screening test for pregnant women that can be used as early as 10 weeks of pregnancy. By evaluating fetal cell-free DNA found in maternal blood, including accurate measurement of the fetal fraction of cfDNA, the test assesses the probability of Trisomy 21 (Down syndrome) and other common fetal chromosomal conditions. The results are intended for prenatal screening and are not intended to be the sole basis for diagnosis. The Harmony® prenatal test has been used to guide clinical care in over 1,400,000 pregnancies worldwide. For more information, visit www.harmonytest.com.
GE Healthcare is a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience and leadership in the healthcare industry and more than 50,000 employees globally, GE Healthcare helps healthcare providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world. Follow us on Facebook, LinkedIn, Twitter and The Pulse for latest news, or visit our website www.gehealthcare.com for more information.
PerkinElmer is a global company focused on improving the health and safety of people and their environment. Within the field of fetal and maternal healthcare, PerkinElmer offers complete screening solutions including instrumentation, reagents and risk calculation software for early detection of pregnancy related anomalies. Annually, more than 10 million prenatal risk assessments are made on the basis of PerkinElmer tests.
PerkinElmer is developing the Vanadis® NIPT system which is an automated non-sequencing, non-PCR based solution for cfDNA analysis. PerkinElmer will in the future offer an easy to use, cost-effective, high-throughput screening test to help facilitate wider access to non-invasive prenatal testing for pregnant women.
PerkinElmer was chosen as the principal screening partner for ASPRE. Throughout the study, the PerkinElmer DELFIA® Xpress PlGF 1-2-3TM assay was used as an aid in screening for pre-eclampsia in conjunction with maternal history, mean arterial blood pressure (MAP) measurement, and UTPi (Uterine Artery Doppler). ASPRE results were published in June 2017 and demonstrated that early screening helps significantly reduce the incidence of preterm pre-eclampsia.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
Canon Medical Systems Europe
Improving the quality of care using innovative technologies
At Canon we strongly believe that technology has a key role to play in making organisations more patient centric and improving quality of care. We are dedicated and develop healthcare technology that enables more effective diagnosis while reducing patient stress. Through services and solutions we seek to grow access to affordable healthcare for humans around the world. We have been working closely with healthcare organizations for over 75 years, in order to develop innovative technological solutions to meet different needs in diagnostic healthcare. Our today’s offer spans from document management to dedicated eye care and digital radiography solutions, to full range of diagnostic imaging solutions.
At Progenity, we provide clear and actionable genetic results that help patients and their families Prepare for Life. Partnering with healthcare providers around the globe to offer the Preparent® Carrier Test. Three test options evaluate carrier status for hereditary disorders that typically affect health in early childhood and include conditions recommended by ACOG. Progenity also offers the Innatal® Prenatal Screen, which provides noninvasive aneuploidy screening for singleton and twin pregnancies with industry-leading sensitivity and specificity and low failure rates. Turn around time for results is typically 5 to 7 days.
Visit us at Booth 6 or at progenity.com.
Thermo Scientific B•R•A•H•M•S Biomarkers investigates, develops and manufactures novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With high-quality immunodiagnostic tests for sepsis, cardiovascular, pulmonary, and cancer disorders as well as prenatal screening we contribute to the creation of a healthier future – to the greatest advantage for medical professionals and patients.In future simple and economic blood tests will be of great importance for an early detection and successful treatment of diseases. With our know-how and technologies we are confident to play an active role in this future: Our products provide important information to clinicians and laboratories in more than 130 countries worldwide, supporting their clinically and economically relevant decisions.
The Gold Standard in Prenatal Screening on KRYPTOR Systems is expanded by adding sFlt-1 for diagnosis of pre-eclampsia Together with the B•R•A•H•M•S PlGF KRYPTOR assay, B•R•A•H•M•S sFlt-1 KRYPTOR improves the diagnosis of pre-eclampsia in 2nd/3rd trimester of pregnancy. The ratio sFlt-1/PlGF is a predictor of adverse outcome in women who develop pre-eclampsia and can advise for a closer monitoring and special care. The latest addition of the sFlt-1 assay as well as the extension of indication for PlGF highly complements Thermo Fisher’s already existing Prenatal Screening portfolio (PAPP-A, Free βhCG, AFP, hCG+β, Fast Screen pre I plus software). Ongoing research and development activities will further contribute to the PNS product range. All B•R•A•H•M•S KRYPTOR platforms are FMF approved and in routine use since 1999,providing reliable results and meeting the highest quality standards of FMF.
Philips is one of the world’s leading technology companies, with a long history of practical innovation and visionary design. In healthcare, we are committed to understanding the human and technological needs of patients and caregivers. We believe this understanding will help us deliver solutions that not only enable more confident diagnoses and more efficient delivery of care, but also improve the overall experience of care. We offer equipment, software, and services for imaging, patient monitoring, resuscitation and much more. Visit us at booth to learn more. People focused. Healthcare simplified.
astraia software is based in Munich, Germany and was founded in 2000. The aim was to develop an independent database application that would cover all aspects of obstetrics and gynaecology to the highest medical standard.
Since then, astraia has established its position as market leader and pioneer in obstetric and gynaecological database applications. The company's success is due to a close working relationship with leading experts worldwide and highly flexible adaptation to market requirements . In many countries astraia is also represented by local sales partners to assure first class customer service. The astraia software solutions provide healthcare professionals with structured data entry screens that guide through the examination, making sure nothing is missed . All data(including measurements and images) is saved securely . It can be accessed any time for later reference or queried for studies and further analysis . Creating a complete and appealing report only takes a few mouse clicks .
From carrier screening, serum screening, NIPT, diagnostic testing, and hereditary cancer testing, Integrated Genetics — a member of the LabCorp Specialty Testing Group — offers a comprehensive genetic testing menu. With over 1,700 patient service centers, the largest commercial genetic counseling network, and an online cost estimator, Integrated Genetics helps you understanDNA.
Wisepress.com, Europe’s leading conference bookseller, has a complete range of books and journals relevant to the themes of the meeting. Books can be purchased at the stand or, if you would rather not carry them, posted to you – Wisepress will deliver worldwide. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers.